SEARCH   
MEMBER LOGIN    

Athlete's Foot Treatment Manufacturing OTC in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Athlete's Foot Treatment Manufacturing OTC Market Research Report | Life Sciences | OTC Medicines | 2012

IBISWorld’s Athlete's Foot Treatment Manufacturing OTC market research report can be used to help you: understand market size and growth potential; major companies; draft business plans and pitch books; and conduct benchmarking and SWOT analysis. Our industry analysis highlights macro industry trends in the overall sector and micro trends faced by companies that do business in the industry. The industry report also provides key industry statistics and 5-year forecasts to anticipate future industry prospects so you can decide with confidence.

Report Snapshot
Market Share of Companies
Bayer AG Bayer AG market share
Novartis Novartis market share
Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC market share
Schering-Plough HealthCare Products, Inc. Schering-Plough HealthCare Products, Inc. market share
Industry Statistics & Market Size
Revenue
Add to Cart
 Annual Growth 07-12
Add to Cart
 Annual Growth 12-17
Add to Cart
Profit
Add to Cart
 Employment
Add to Cart
 Businesses
Add to Cart
What is the Athlete's Foot Treatment Manufacturing OTC industry?

This industry manufactures medications to treat common fungal infections of the skin that cause scaling, flaking and itching. This industry includes products that are sold without a prescription... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents
Major products in this industry
Miconazole nitrate-based solutionsTolnaftate-based solutionsTerbinafine-based solutions
 
Examples of brands in this Industry
Lotrimin (Schering-Plough HealthCare Products) Caneston (Bayer)Lamisil (Novartis Consumer Health)Gold Bond (Sanofi Aventis)


View Sample
Quote
Select Clients